Skip to main content
Clinical Trials/CTRI/2019/01/017322
CTRI/2019/01/017322Not yet recruitingPhase 1

Comparison of intrathecal Bupivacaine and Bupivacaine plus Midazolam in spinal analgesia. - Bupivacaine, Midazolam, Spinal analgesia

Peoples College of Medical Sciences R C0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Total 100 patients of ASA Grade I and II between the age group of 25 to 50 years of age undergoing surgery below umbilicus under spinal analgesia will be taken.

Exclusion Criteria

  • Patients with H/O long-term uncontrolled hypertension, uncontrolled DM cases, known neurologic or psychological disorders, spinal column surgery, with low back pain, chronic alcoholism, opium addiction or on any drug that modifies pain will not be included in this study. Patient with coagulation abnormality, patient with infection at the site of injection will also be excluded

Investigators

Sponsor
Peoples College of Medical Sciences R C

Similar Trials